|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,205.80 INR | -1.52% |
|
-3.55% | -3.70% |
| 07-13 | Asian Equities Traded in the US as American Depositary Receipts Advance in Monday Trading | MT |
| 07-10 | Asian Equities Traded in the US as American Depositary Receipts Rise in Friday Trading | MT |
| Market Cap | 1,019B 10.58B 9.25B 8.55B 7.85B 14.85B 15.11B 102B 40.05B 498B 39.72B 38.85B 1,718B | P/E 2027 * |
24.2x | P/E 2028 * | 19.4x |
|---|---|---|---|---|---|
| Enterprise Value | 986B 10.24B 8.95B 8.28B 7.59B 14.37B 14.62B 98.7B 38.77B 482B 38.45B 37.6B 1,663B | EV / Sales 2027 * |
2.77x | EV / Sales 2028 * | 2.44x |
| Free-Float |
70.07% | Yield 2027 * |
0.63% | Yield 2028 * | 0.69% |
Last Transcript: Dr. Reddy's Laboratories Limited
| 1 week | -3.55% | ||
| Current month | -9.78% | ||
| 1 month | -4.11% | ||
| 3 months | +0.25% | ||
| 6 months | +4.16% | ||
| Current year | -3.70% |
| 1 week | 1,204 | 1,251.8 | |
| 1 month | 1,204 | 1,414.9 | |
| 3 years | 1,018.6 | 1,421.49 | |
| 5 years | 730.8 | 1,421.49 | |
| 10 years | 374.59 | 1,421.49 |
| Manager | Title | Age | Since |
|---|---|---|---|
Erez Israeli
CEO | Chief Executive Officer | 59 | 2019-06-30 |
| Director of Finance/CFO | - | 2024-07-31 | |
Sanjay Sharma
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 58 | 2014-05-12 | |
Gunupati Prasad
CHM | Chairman | 65 | 2013-04-01 |
Leo Puri
BRD | Director/Board Member | 65 | 2018-10-24 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.52% | -3.55% | -2.78% | +20.23% | 10.58B | ||
| +1.08% | -3.93% | +48.03% | +160.13% | 1,043B | ||
| +1.19% | -3.52% | +51.70% | +56.36% | 602B | ||
| +4.21% | +1.79% | +33.48% | +87.04% | 449B | ||
| +0.27% | -1.07% | +29.57% | +24.16% | 327B | ||
| +0.70% | 0.00% | +33.15% | +46.35% | 279B | ||
| -0.36% | -1.81% | +22.21% | +23.55% | 264B | ||
| +3.70% | +2.19% | +24.27% | +63.38% | 201B | ||
| +3.49% | +1.08% | +24.08% | +76.58% | 169B | ||
| +1.29% | +3.67% | +2.15% | -30.78% | 143B | ||
| Average | +1.43% | -0.68% | +26.59% | +52.70% | 386.34B | |
| Weighted average by Cap. | +1.57% | -1.82% | +37.34% | +82.72% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 356B 3.7B 3.23B 2.99B 2.74B 5.19B 5.28B 35.63B 14B 174B 13.88B 13.57B 600B | 395B 4.1B 3.58B 3.31B 3.04B 5.76B 5.86B 39.53B 15.53B 193B 15.4B 15.06B 666B |
| Net income | 42.32B 439M 384M 355M 326M 617M 627M 4.23B 1.66B 20.67B 1.65B 1.61B 71.34B | 53.04B 550M 481M 445M 408M 773M 786M 5.31B 2.08B 25.9B 2.07B 2.02B 89.43B |
| Net Debt | -32.67B -339M -296M -274M -251M -476M -484M -3.27B -1.28B -15.95B -1.27B -1.25B -55.07B | -54.24B -563M -492M -455M -418M -790M -804M -5.43B -2.13B -26.49B -2.11B -2.07B -91.45B |
| Date | Price | Change |
|---|---|---|
| 26-07-17 | ₹1,205.80 | -1.52% |
| 26-07-16 | ₹1,224.40 | -0.41% |
| 26-07-15 | ₹1,229.50 | -1.34% |
| 26-07-14 | ₹1,246.20 | +0.95% |
| 26-07-13 | ₹1,234.50 | -0.79% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- DRREDDY Stock
- DRREDDY Stock
Select your edition
All financial news and data tailored to specific country editions


















